Skip to main content
. 2020 Feb 27;10:3653. doi: 10.1038/s41598-020-60443-2

Figure 2.

Figure 2

Effect of PG-CAT treatment on RSV disease in mice. BALB/c mice were either un-infected and treated with PBS or PG-CAT (PBS – PBS or PG-CAT – PBS), or infected and D0 and treated at D(−1) and D(1) with PBS, PG only, or PG-CAT (PBS – RSV, PG – RSV, and PG-CAT – RSV) (A). Mice were assessed for: body weight loss (B); clinical disease score (C); lung viral titers by plaque assays at day 5 p.i. (D); BALF total protein concentration at day 2 p.i. (E); airway obstruction by whole body plethysmography (F). Data are mean ± SEM. Significance was determined using repeated measures ANOVA (B, C, and F), one-way ANOVA (E) and student’s t-test (D). Tukey’s multiple comparison analysis was used for inter-group analysis. *p < 0.05, **p < 0.01, and ***p < 0.001 is significance for PBS – RSV vs PG-CAT – RSV. ^p < 0.05, ^^p < 0.01, and ^^^p < 0.001 is significance for PG – RSV v PG-CAT – RSV.